SANWA KAGAKU KENKYUSHO CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Subsidiary
- Established
- 1953-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.skk-net.com
Phase 3 Study of SK-1403
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 153
- Registration Number
- NCT03801980
- Locations
- π―π΅
Investigational site (there may be other sites in this country), Tokyo, Japan
SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 157
- Registration Number
- NCT03626948
- Locations
- π―π΅
Investigational site (there may be other sites in this country), Tokyo, Japan
Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2019-03-15
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT03226171
- Locations
- π―π΅
Investigational site (there may be other sites in this country), Tokyo, Japan
A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 269
- Registration Number
- NCT03218501
- Locations
- π―π΅
Investigational site (there may be other sites in this country), Tokyo, Japan
Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT03116191
- Locations
- π―π΅
Investigational site (there may be other sites in this country), Tokyo, Japan
Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT02878096
- Locations
- π¬π§
Quotient Clinical, Ruddington, Nottingham, United Kingdom
A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405
- First Posted Date
- 2016-07-27
- Last Posted Date
- 2016-11-23
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT02846181
- Locations
- π¬π§
Quotient Clinical Ltd., Nottingham, United Kingdom
A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects
- First Posted Date
- 2016-01-08
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Registration Number
- NCT02650076
- Locations
- π¬π§
Hammersmith Medicines Research, London, United Kingdom
Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-12-30
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02327754
- Locations
- π―π΅
Sanwa Kagaku Kenkyusho Co., Ltd., Nagoya, Aichi, Japan
A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Registration Number
- NCT02100267
- Locations
- π―π΅
Showa University Clinical Research Center, Setagaya-ku, Tokyo, Japan
Β© Copyright 2024. All Rights Reserved by MedPath